期刊
JOURNAL OF IMMUNOLOGY
卷 174, 期 9, 页码 5823-5829出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.174.9.5823
关键词
-
类别
资金
- NHLBI NIH HHS [HL67424] Funding Source: Medline
We addressed the regulatory function of mammalian target of rapamycin (mTOR) in the mechanism of thrombin-induced ICAM-1 gene expression in endothelial cells. Pretreatment of HUVECs with rapamycin, an inhibitor of mTOR, augmented thrombin-induced ICAM-1 expression. Inhibition of mTOR by this approach promoted whereas over-expression of mTOR inhibited thrombin-induced transcriptional activity of NF-kappa B, an essential regulator of ICAM-I transcription. Analysis of the NF-kappa B signaling pathway revealed that inhibition of mTOR potentiated I kappa B kinase activation resulting in a rapid and persistent phosphorylation of I kappa B alpha on Ser32 and Ser36, a requirement for I kappa B alpha degradation. Consistent with these data, we observed a more efficient and stable nuclear localization of RelA/p65 and, subsequently, the DNA binding activity of NF-kappa B by thrombin following mTOR inhibition. These data define a novel role of mTOR in down-regulating thrombin-induced ICAM-I expression in endothelial cells by controlling a delayed and transient activation of NF-kappa B.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据